Non-Current Liabilities
Liability For Uncertain Tax Positions Noncurrent
Pfizer Liability For Uncertain Tax Positions Noncurrent increased by 3.2% to $3.71B in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
An increase suggests higher tax audit risk or aggressive tax planning, while a decrease indicates the resolution of past tax uncertainties.
Detailed definition
This represents the estimated liability for tax positions taken by the company that may be challenged by tax authorities...
Peer comparison
Standard for multinational corporations operating in multiple jurisdictions with complex tax environments.
Metric ID:
non_current_liabilities_liability_for_uncertain_tax_posi_541f68Historical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $3.59B | $3.71B |
| QoQ Change | — | +3.2% |
Range$3.59B – $3.71B
Liability For Uncertain Tax Positions Noncurrent at Other Companies
Frequently Asked Questions
- What is Pfizer's liability for uncertain tax positions noncurrent?
- Pfizer (PFE) reported liability for uncertain tax positions noncurrent of $3.71B in Q1 2026.
- What does liability for uncertain tax positions noncurrent mean?
- The estimated amount set aside for potential tax payments resulting from disputed tax filings.